These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22252512)

  • 1. Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors.
    Cottingham MG; Carroll F; Morris SJ; Turner AV; Vaughan AM; Kapulu MC; Colloca S; Siani L; Gilbert SC; Hill AV
    Biotechnol Bioeng; 2012 Mar; 109(3):719-28. PubMed ID: 22252512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of E1- and E3-deleted adenovirus vectors expressing two antigens from two separate expression cassettes.
    Small JC; Kurupati RK; Zhou X; Bian A; Chi E; Li Y; Xiang Z; Ertl HC
    Hum Gene Ther; 2014 Apr; 25(4):328-38. PubMed ID: 24367921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles.
    Murakami P; Pungor E; Files J; Do L; van Rijnsoever R; Vogels R; Bout A; McCaman M
    Hum Gene Ther; 2002 May; 13(8):909-20. PubMed ID: 12031124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordant activity of transgene expression cassettes inserted into E1, E3 and E4 cloning sites in the adenovirus genome.
    Pham L; Nakamura T; Gabriela Rosales A; Carlson SK; Bailey KR; Peng KW; Russell SJ
    J Gene Med; 2009 Mar; 11(3):197-206. PubMed ID: 19140107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches.
    Murakami P; Havenga M; Fawaz F; Vogels R; Marzio G; Pungor E; Files J; Do L; Goudsmit J; McCaman M
    J Virol; 2004 Jun; 78(12):6200-8. PubMed ID: 15163713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of recombinant adenovirus vector with infectious adenoviral genome released from cosmid-based vector by simple procedure allowing complex manipulation.
    Kojima H; Ohishi N; Yagi K
    Biochem Biophys Res Commun; 1998 May; 246(3):868-72. PubMed ID: 9618304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
    Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
    Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid yeast-bacteria cloning system used to capture and modify adenoviral and nonviral genomes.
    Hokanson CA; Dora E; Donahue BA; Rivkin M; Finer M; Mendez MJ
    Hum Gene Ther; 2003 Mar; 14(4):329-39. PubMed ID: 12659674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products.
    Haut LH; Gill AL; Kurupati RK; Bian A; Li Y; Giles-Davis W; Xiang Z; Zhou XY; Ertl HC
    Hum Gene Ther Methods; 2016 Oct; 27(5):187-196. PubMed ID: 27604324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
    Oualikene W; Lamoureux L; Weber JM; Massie B
    Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.
    Catalucci D; Sporeno E; Cirillo A; Ciliberto G; Nicosia A; Colloca S
    J Virol; 2005 May; 79(10):6400-9. PubMed ID: 15858023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Autoreplication' of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes.
    Marienfeld U; Haack A; Thalheimer P; Schneider-Rasp S; Brackmann HH; Poller W
    Gene Ther; 1999 Jun; 6(6):1101-13. PubMed ID: 10455413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a packaging cell line for propagation of replication-deficient adenovirus vector.
    Kim JS; Lee SH; Cho YS; Park K; Kim YH; Lee JH
    Exp Mol Med; 2001 Sep; 33(3):145-9. PubMed ID: 11642550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication-competent adenovirus formation in 293 cells: the recombination-based rate is influenced by structure and location of the transgene cassette and not increased by overproduction of HsRad51, Rad51-interacting, or E2F family proteins.
    Duigou GJ; Young CS
    J Virol; 2005 May; 79(9):5437-44. PubMed ID: 15827158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology of E1-deleted adenovirus vectors in nonhuman primate muscle.
    Zoltick PW; Chirmule N; Schnell MA; Gao GP; Hughes JV; Wilson JM
    J Virol; 2001 Jun; 75(11):5222-9. PubMed ID: 11333904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue and production of vaccine and therapeutic adenovirus vectors expressing inhibitory transgenes.
    Gall JG; Lizonova A; EttyReddy D; McVey D; Zuber M; Kovesdi I; Aughtman B; King CR; Brough DE
    Mol Biotechnol; 2007 Mar; 35(3):263-73. PubMed ID: 17652790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
    Hoffmann D; Wildner O
    BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.
    Kuzmin AI; Galenko O; Eisensmith RC
    Mol Ther; 2001 Mar; 3(3):293-301. PubMed ID: 11273770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence.
    Hehir KM; Armentano D; Cardoza LM; Choquette TL; Berthelette PB; White GA; Couture LA; Everton MB; Keegan J; Martin JM; Pratt DA; Smith MP; Smith AE; Wadsworth SC
    J Virol; 1996 Dec; 70(12):8459-67. PubMed ID: 8970968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of transgene expression in adenoviral vector-based HIV-1 vaccine candidates.
    Takahashi MN; Rolling JA; Owen KE
    Virol J; 2010 Feb; 7():39. PubMed ID: 20163742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.